These findings strongly support the view that the Tam-induced release of lysosomal Ca2+ is the main molecular mechanism accounting for the greater nuclear relocation of TFEB detected in MCF7-TamR cells stably growing in the presence of the drug, as well as in the parental breast cancer cell lines transiently treated with the drug. The gene discussed is TFEB; the disease is breast cancer.